Figure 1.
The effect of gefitinib on the tumor-producing capabilities of p53 null mammary epithelium transplanted into virgin or pituitary-isograft bearing mice. Gefitinib delayed tumorigenesis in virgin mice () compared to sham controls (
). Gefitinib did not have any effect on tumorigenesis in hormone-stimulated hosts.